-
1
-
-
60249094472
-
CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey NHANES
-
PMID: 19231761
-
Castro AF, Coresh J. CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009; 53(Suppl 3):S46-55; PMID: 19231761; http://dx.doi.org/10.1053/ j.ajkd.2008.07.054
-
(2009)
Am J Kidney Dis
, vol.53
, Issue.SUPPL. 3
-
-
Castro, A.F.1
Coresh, J.2
-
2
-
-
83055172414
-
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
-
National Kidney Foundation PMID:14520607
-
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 (Suppl 3):S1-201; PMID:14520607; http://dx.doi.org/10.1016/S0272-6386(03)00553-5
-
(2003)
Am J Kidney Dis
, vol.42
, Issue.SUPPL. 3
-
-
-
3
-
-
82455162521
-
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
-
PMID:21993585
-
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80:1258-70; PMID:21993585; http://dx.doi.org/10.1038/ki.2011.368
-
(2011)
Kidney Int
, vol.80
, pp. 1258-1270
-
-
Couser, W.G.1
Remuzzi, G.2
Mendis, S.3
Tonelli, M.4
-
4
-
-
79956198995
-
Vitamin d therapy and cardiovascular health
-
PMID:21298577
-
Judd SE, Tangpricha V. Vitamin d therapy and cardiovascular health. Curr Hypertens Rep 2011; 13:187-91; PMID:21298577; http://dx.doi.org/10.1007/s11906- 011-0190-2
-
(2011)
Curr Hypertens Rep
, vol.13
, pp. 187-191
-
-
Judd, S.E.1
Tangpricha, V.2
-
5
-
-
77954562871
-
Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity
-
Berl PMID:20119827
-
Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) 2010; 88:441-50; PMID:20119827; http://dx.doi.org/10.1007/s00109-010-0590-9
-
(2010)
J Mol Med
, vol.88
, pp. 441-450
-
-
Kamen, D.L.1
Tangpricha, V.2
-
6
-
-
80051919112
-
Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies
-
PMID:21636193
-
Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011; 58:374-82; PMID:21636193
-
(2011)
Am J Kidney Dis
, vol.58
, pp. 374-382
-
-
Pilz, S.1
Iodice, S.2
Zittermann, A.3
Grant, W.B.4
Gandini, S.5
-
7
-
-
84865160040
-
D and the Kidney
-
Feldman DP, J.W.; Adams, J.S., ed. Amsterdam: Elsevier Inc
-
Tebben PK, Vitamin R. D and the Kidney. In: Feldman DP, J.W.; Adams, J.S., ed. Vitamin D. Amsterdam: Elsevier Inc, 2011:471-91.
-
(2011)
Vitamin D
, pp. 471-491
-
-
Tebben, P.K.1
Vitamin, R.2
-
8
-
-
84865160043
-
Vitamin D and Renal Disease
-
Feldman DP, J.W.; Adams, J.S., ed. Amsterdam: Elsevier Inc
-
Dusso ASS. E. Vitamin D and Renal Disease. In: Feldman DP, J.W.; Adams, J.S., ed. Vitamin D. Amsterdam: Elsevier Inc, 2011:1325-57.
-
(2011)
Vitamin D
, pp. 1325-1357
-
-
Dusso, A.S.S.E.1
-
9
-
-
34547208630
-
Expanding role for vitamin D in chronic kidney disease: Importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D (3)
-
PMID:17635821
-
Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D (3). Semin Dial 2007; 20:316-24; PMID:17635821; http://dx.doi.org/10.1111/j.1525-139X.2007. 00302.x
-
(2007)
Semin Dial
, vol.20
, pp. 316-324
-
-
Jones, G.1
-
10
-
-
27744545673
-
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
-
PMID:15917335
-
Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16:2205-15; PMID:15917335; http://dx.doi.org/10.1681/ASN.2005010052
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2205-2215
-
-
Gutierrez, O.1
Isakova, T.2
Rhee, E.3
Shah, A.4
Holmes, J.5
Collerone, G.6
-
11
-
-
36049037977
-
Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro
-
PMID:17699549
-
Perwad F, Zhang MY, Tenenhouse HS, Portale AA. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol 2007; 293:F1577-83; PMID:17699549; http://dx.doi.org/10.1152/ajprenal. 00463.2006
-
(2007)
Am J Physiol Renal Physiol
, vol.293
-
-
Perwad, F.1
Zhang, M.Y.2
Tenenhouse, H.S.3
Portale, A.A.4
-
12
-
-
36248990247
-
Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis
-
PMID:17805236
-
Usatii M, Rousseau L, Demers C, Petit JL, Brossard JH, Gascon-Barré M, et al. Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis. Kidney Int 2007; 72:1330-5; PMID:17805236; http://dx.doi.org/10.1038/sj.ki.5002532
-
(2007)
Kidney Int
, vol.72
, pp. 1330-1335
-
-
Usatii, M.1
Rousseau, L.2
Demers, C.3
Petit, J.L.4
Brossard, J.H.5
Gascon-Barré, M.6
-
13
-
-
0026936443
-
Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity
-
PMID:1450371
-
Hsu CH, Patel S. Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity. J Am Soc Nephrol 1992; 3:947-52; PMID:1450371
-
(1992)
J Am Soc Nephrol
, vol.3
, pp. 947-952
-
-
Hsu, C.H.1
Patel, S.2
-
14
-
-
73249146058
-
Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease
-
PMID:19661219
-
Kalantar-Zadeh K, Kovesdy CP. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4:1529-39; PMID:19661219; http://dx.doi.org/10.2215/CJN.02140309
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 1529-1539
-
-
Kalantar-Zadeh, K.1
Kovesdy, C.P.2
-
15
-
-
49849086981
-
Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: Evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment
-
PMID: 18724068
-
Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, et al. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 2008; 110:c58-65; PMID: 18724068; http://dx.doi.org/10.1159/000151534
-
(2008)
Nephron Clin Pract
, vol.110
-
-
Jean, G.1
Terrat, J.C.2
Vanel, T.3
Hurot, J.M.4
Lorriaux, C.5
Mayor, B.6
-
16
-
-
84856376868
-
Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis
-
PMID:22237061
-
Wasse H, Huang R, Long Q, Singapuri S, Raggi P, Tangpricha V. Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis. Am J Clin Nutr 2012; 95:522-8; PMID:22237061; http://dx.doi.org/10.3945/ajcn. 111.025502
-
(2012)
Am J Clin Nutr
, vol.95
, pp. 522-528
-
-
Wasse, H.1
Huang, R.2
Long, Q.3
Singapuri, S.4
Raggi, P.5
Tangpricha, V.6
-
17
-
-
34447514029
-
Vitamin D deficiency
-
PMID:17634462
-
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81; PMID:17634462; http://dx.doi.org/10.1056/NEJMra070553
-
(2007)
N Engl J Med
, vol.357
, pp. 266-281
-
-
Holick, M.F.1
-
18
-
-
79960104336
-
Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline
-
PMID:21646368
-
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-30; PMID:21646368; http://dx.doi.org/10.1210/jc.2011-0385
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 1911-1930
-
-
Holick, M.F.1
Binkley, N.C.2
Bischoff-Ferrari, H.A.3
Gordon, C.M.4
Hanley, D.A.5
Heaney, R.P.6
-
19
-
-
20444428708
-
Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States
-
PMID: 15957131
-
LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 2005; 45:1026-33; PMID: 15957131; http://dx.doi.org/10.1053/j.ajkd.2005.02.029
-
(2005)
Am J Kidney Dis
, vol.45
, pp. 1026-1033
-
-
LaClair, R.E.1
Hellman, R.N.2
Karp, S.L.3
Kraus, M.4
Ofner, S.5
Li, Q.6
-
20
-
-
49249095954
-
Hypovitaminosis D in chronic kidney disease
-
PMID:18417740
-
Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3:1144-51; PMID:18417740; http://dx.doi.org/10.2215/CJN.05781207
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1144-1151
-
-
Mehrotra, R.1
Kermah, D.2
Budoff, M.3
Salusky, I.B.4
Mao, S.S.5
Gao, Y.L.6
-
21
-
-
84855688275
-
Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis
-
PMID:21924736
-
Robinson AB, Thierry-Palmer M, Gibson KL, Rabinovich CE. Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis. J Pediatr 2012; 160:297-302; PMID:21924736; http://dx.doi.org/10.1016/j.jpeds.2011.08.011
-
(2012)
J Pediatr
, vol.160
, pp. 297-302
-
-
Robinson, A.B.1
Thierry-Palmer, M.2
Gibson, K.L.3
Rabinovich, C.E.4
-
22
-
-
79952709139
-
Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: A downward spiral in kidney disease
-
PMID:21270766
-
Dusso AS, Tokumoto M. Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int 2011; 79:715-29; PMID:21270766; http://dx.doi.org/10.1038/ ki.2010.543
-
(2011)
Kidney Int
, vol.79
, pp. 715-729
-
-
Dusso, A.S.1
Tokumoto, M.2
-
23
-
-
0033582543
-
An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3
-
PMID:10052453
-
Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96:507-15; PMID:10052453; http://dx.doi.org/10. 1016/S0092-8674(00)80655-8
-
(1999)
Cell
, vol.96
, pp. 507-515
-
-
Nykjaer, A.1
Dragun, D.2
Walther, D.3
Vorum, H.4
Jacobsen, C.5
Herz, J.6
-
24
-
-
79957485698
-
Extra-skeletal effects of vitamin D deficiency in chronic kidney disease
-
PMID:21214426
-
Chonchol M, Kendrick J, Targher G. Extra-skeletal effects of vitamin D deficiency in chronic kidney disease. Ann Med 2011; 43:273-82; PMID:21214426; http://dx.doi.org/10.3109/07853890.2010.543923
-
(2011)
Ann Med
, vol.43
, pp. 273-282
-
-
Chonchol, M.1
Kendrick, J.2
Targher, G.3
-
25
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
PMID:15385656
-
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-305; PMID:15385656; http://dx.doi.org/10.1056/NEJMoa041031
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
26
-
-
1942506539
-
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies
-
PMID:15100371
-
Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15:1307-15; PMID:15100371; http://dx.doi.org/10.1097/01.ASN. 0000123691.46138.E2
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 1307-1315
-
-
Weiner, D.E.1
Tighiouart, H.2
Amin, M.G.3
Stark, P.C.4
MacLeod, B.5
Griffith, J.L.6
-
27
-
-
80053053192
-
Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD
-
PMID:21816525
-
Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ, Jr., et al. Low 25-hydroxyvitamin D levels and mortality in non-dialysis- dependent CKD. Am J Kidney Dis 2011; 58:536-43; PMID:21816525; http://dx.doi.org/10.1053/j.ajkd.2011.04.028
-
(2011)
Am J Kidney Dis
, vol.58
, pp. 536-543
-
-
Navaneethan, S.D.1
Schold, J.D.2
Arrigain, S.3
Jolly, S.E.4
Jain, A.5
Schreiber Jr., M.J.6
-
28
-
-
84455188819
-
Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies
-
PMID:22170374
-
Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95:91-100; PMID:22170374; http://dx.doi.org/10.3945/ajcn.111.014779
-
(2012)
Am J Clin Nutr
, vol.95
, pp. 91-100
-
-
Zittermann, A.1
Iodice, S.2
Pilz, S.3
Grant, W.B.4
Bagnardi, V.5
Gandini, S.6
-
29
-
-
40649108122
-
Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: A randomized controlled pilot study
-
PMID: 18238736
-
Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 2008; 14:10-7; PMID: 18238736
-
(2008)
Endocr Pract
, vol.14
, pp. 10-17
-
-
Chandra, P.1
Binongo, J.N.2
Ziegler, T.R.3
Schlanger, L.E.4
Wang, W.5
Someren, J.T.6
-
30
-
-
84857188798
-
Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: A randomized trial
-
PMID:22266572
-
Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C, et al. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 2012; 7:216-23; PMID:22266572; http://dx.doi.org/10.2215/CJN.04760511
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 216-223
-
-
Shroff, R.1
Wan, M.2
Gullett, A.3
Ledermann, S.4
Shute, R.5
Knott, C.6
-
31
-
-
83655191998
-
Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: A randomized controlled trial
-
PMID:21885174
-
Kovesdy CP, Lu JL, Malakauskas SM, Andress DL, Kalantar-Zadeh K, Ahmadzadeh S. Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Am J Kidney Dis 2012; 59:58-66; PMID:21885174; http://dx.doi.org/10.1053/j.ajkd.2011. 06.027
-
(2012)
Am J Kidney Dis
, vol.59
, pp. 58-66
-
-
Kovesdy, C.P.1
Lu, J.L.2
Malakauskas, S.M.3
Andress, D.L.4
Kalantar-Zadeh, K.5
Ahmadzadeh, S.6
-
32
-
-
77749334653
-
A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease
-
PMID:20056760
-
Moe SM, Saifullah A, LaClair RE, Usman SA, Yu Z. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. Clin J Am Soc Nephrol 2010; 5:299-306; PMID:20056760; http://dx.doi.org/10.2215/CJN.07131009
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 299-306
-
-
Moe, S.M.1
Saifullah, A.2
LaClair, R.E.3
Usman, S.A.4
Yu, Z.5
-
33
-
-
45749147117
-
Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients
-
PMID:18569914
-
Dogan E, Erkoc R, Sayarlioglu H, Soyoral Y, Dulger H. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients. Ren Fail 2008; 30:407-10; PMID:18569914; http://dx.doi.org/10.1080/08860220801964210
-
(2008)
Ren Fail
, vol.30
, pp. 407-410
-
-
Dogan, E.1
Erkoc, R.2
Sayarlioglu, H.3
Soyoral, Y.4
Dulger, H.5
-
34
-
-
66349087471
-
Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease
-
PMID:19229821
-
Rucker D, Tonelli M, Coles MG, Yoo S, Young K, McMahon AW. Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease. J Nephrol 2009; 22:75-82; PMID:19229821
-
(2009)
J Nephrol
, vol.22
, pp. 75-82
-
-
Rucker, D.1
Tonelli, M.2
Coles, M.G.3
Yoo, S.4
Young, K.5
McMahon, A.W.6
-
35
-
-
83755184301
-
Effect of cholecalciferol on parathyroid hormone and vitamin D levels in chronic kidney disease
-
PMID:21996984
-
Taner B, Abdulkadir U. Effect of cholecalciferol on parathyroid hormone and vitamin D levels in chronic kidney disease. Minerva Urol Nefrol 2011; 63:287-92; PMID:21996984
-
(2011)
Minerva Urol Nefrol
, vol.63
, pp. 287-292
-
-
Taner, B.1
Abdulkadir, U.2
-
36
-
-
51849139805
-
Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease
-
PMID: 18802363
-
Oksa A, Spustová V, Krivosíková Z, Gazdíková K, Fedelesová V, Lajdová I, et al. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res 2008; 31:322-9; PMID: 18802363; http://dx.doi.org/10.1159/000157177
-
(2008)
Kidney Blood Press Res
, vol.31
, pp. 322-329
-
-
Oksa, A.1
Spustová, V.2
Krivosíková, Z.3
Gazdíková, K.4
Fedelesová, V.5
Lajdová, I.6
-
37
-
-
78449284356
-
Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease
-
PMID:20872152
-
Hari P, Gupta N, Hari S, Gulati A, Mahajan P, Bagga A. Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease. Pediatr Nephrol 2010; 25:2483-8; PMID:20872152; http://dx.doi.org/10. 1007/s00467-010-1639-2
-
(2010)
Pediatr Nephrol
, vol.25
, pp. 2483-2488
-
-
Hari, P.1
Gupta, N.2
Hari, S.3
Gulati, A.4
Mahajan, P.5
Bagga, A.6
-
38
-
-
33845666128
-
Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease
-
Carlton PMID:17199797
-
DeVille J, Thorp ML, Tobin L, Gray E, Johnson ES, Smith DH. Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton) 2006; 11:555-9; PMID:17199797; http://dx.doi.org/10.1111/j.1440-1797.2006.00698.x
-
(2006)
Nephrology
, vol.11
, pp. 555-559
-
-
DeVille, J.1
Thorp, M.L.2
Tobin, L.3
Gray, E.4
Johnson, E.S.5
Smith, D.H.6
-
39
-
-
77956397475
-
Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency
-
PMID:20718162
-
Trakarnvanich T, Chalapipat O, Disthabanchong S, Kurathong S, Praditpornsilpa K, Stitchantrakul W, et al. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency. J Med Assoc Thai 2010; 93:885-91; PMID:20718162
-
(2010)
J Med Assoc Thai
, vol.93
, pp. 885-891
-
-
Trakarnvanich, T.1
Chalapipat, O.2
Disthabanchong, S.3
Kurathong, S.4
Praditpornsilpa, K.5
Stitchantrakul, W.6
-
40
-
-
33847669753
-
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease
-
PMID: 17215573
-
Zisman AL, Hristova M, Ho LT, Sprague SM. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 2007; 27:36-43; PMID: 17215573; http://dx.doi.org/10.1159/000098561
-
(2007)
Am J Nephrol
, vol.27
, pp. 36-43
-
-
Zisman, A.L.1
Hristova, M.2
Ho, L.T.3
Sprague, S.M.4
-
41
-
-
84888298793
-
Treatment of 25-OH Vitamin D Deficiency in Older Men with Chronic Kidney Disease Stages 3 and 4 Is Associated with Reduction in Cardiovascular Events
-
PMID:22185755
-
Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A. Treatment of 25-OH Vitamin D Deficiency in Older Men With Chronic Kidney Disease Stages 3 and 4 Is Associated With Reduction in Cardiovascular Events. Am J Ther 2011; PMID:22185755; http://dx.doi.org/10.1097/MJT.0b013e3182211b3b
-
(2011)
Am J Ther
-
-
Lishmanov, A.1
Dorairajan, S.2
Pak, Y.3
Chaudhary, K.4
Chockalingam, A.5
-
42
-
-
34250771472
-
Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD
-
PMID:17591525
-
Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 2007; 50:59-68; PMID:17591525; http://dx.doi.org/10.1053/j.ajkd.2007.04.010
-
(2007)
Am J Kidney Dis
, vol.50
, pp. 59-68
-
-
Al-Aly, Z.1
Qazi, R.A.2
González, E.A.3
Zeringue, A.4
Martin, K.J.5
-
43
-
-
51549115434
-
Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease
-
PMID:18575896
-
Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 2008; 23:1831-6; PMID:18575896; http://dx.doi.org/10.1007/ s00467-008-0842-x
-
(2008)
Pediatr Nephrol
, vol.23
, pp. 1831-1836
-
-
Menon, S.1
Valentini, R.P.2
Hidalgo, G.3
Peschansky, L.4
Mattoo, T.K.5
-
44
-
-
77950793603
-
Treatment of vitamin D deficiency in CKD patients with ergocalciferol: Are current K/DOQI treatment guidelines adequate?
-
PMID:20353735
-
Qunibi WY, Abdellatif A, Sankar S, Hamdan Z, Lin FY, Ingle J, et al. Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate? Clin Nephrol 2010; 73:276-85; PMID:20353735
-
(2010)
Clin Nephrol
, vol.73
, pp. 276-285
-
-
Qunibi, W.Y.1
Abdellatif, A.2
Sankar, S.3
Hamdan, Z.4
Lin, F.Y.5
Ingle, J.6
-
45
-
-
73949131479
-
Intracellular calcium homeostasis in patients with early stages of chronic kidney disease: Effects of vitamin D3 supplementation
-
PMID:19531669
-
Lajdova I, Spustova V, Oksa A, Chorvatova A, Chorvat D, Jr., Dzurik R. Intracellular calcium homeostasis in patients with early stages of chronic kidney disease: effects of vitamin D3 supplementation. Nephrol Dial Transplant 2009; 24:3376-81; PMID:19531669; http://dx.doi.org/10.1093/ndt/gfp292
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 3376-3381
-
-
Lajdova, I.1
Spustova, V.2
Oksa, A.3
Chorvatova, A.4
Chorvat Jr., D.5
Dzurik, R.6
-
46
-
-
84875257184
-
Can vitamin D slow down the progression of chronic kidney disease?
-
PMID:22160397
-
Shroff R, Wan M, Rees L. Can vitamin D slow down the progression of chronic kidney disease? Pediatr Nephrol 2011; PMID:22160397; http://dx.doi.org/10.1007/s00467-011-2071-y
-
(2011)
Pediatr Nephrol
-
-
Shroff, R.1
Wan, M.2
Rees, L.3
-
47
-
-
70350077680
-
Chronic kidney disease, hypovitaminosis D, and mortality in the United States
-
PMID:19657329
-
Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009; 76:977-83; PMID:19657329; http://dx.doi.org/10.1038/ki.2009.288
-
(2009)
Kidney Int
, vol.76
, pp. 977-983
-
-
Mehrotra, R.1
Kermah, D.A.2
Salusky, I.B.3
Wolf, M.S.4
Thadhani, R.I.5
Chiu, Y.W.6
-
48
-
-
72049115797
-
25-hydroxyvitamin D levels, race, and the progression of kidney disease
-
PMID:19875805
-
Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009; 20:2631-9; PMID:19875805; http://dx.doi.org/10.1681/ASN. 2009030283
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 2631-2639
-
-
Melamed, M.L.1
Astor, B.2
Michos, E.D.3
Hostetter, T.H.4
Powe, N.R.5
Muntner, P.6
-
49
-
-
58149156441
-
Vitamin D levels and patient outcome in chronic kidney disease
-
PMID:18843258
-
Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75:88-95; PMID:18843258; http://dx.doi.org/10.1038/ki.2008.501
-
(2009)
Kidney Int
, vol.75
, pp. 88-95
-
-
Ravani, P.1
Malberti, F.2
Tripepi, G.3
Pecchini, P.4
Cutrupi, S.5
Pizzini, P.6
-
50
-
-
8744276604
-
Vitamin D2 is much less effective than vitamin D3 in humans
-
PMID: 15531486
-
Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89:5387-91; PMID: 15531486; http://dx.doi.org/10.1210/jc.2004-0360
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5387-5391
-
-
Armas, L.A.1
Hollis, B.W.2
Heaney, R.P.3
-
51
-
-
79951842205
-
Vitamin D(3) is more potent than vitamin D(2) in humans
-
PMID:21177785
-
Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011; 96:E447-52; PMID:21177785; http://dx.doi.org/10.1210/jc.2010-2230
-
(2011)
J Clin Endocrinol Metab
, vol.96
-
-
Heaney, R.P.1
Recker, R.R.2
Grote, J.3
Horst, R.L.4
Armas, L.A.5
-
52
-
-
0031594960
-
Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2
-
PMID:9771862
-
Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998; 68:854-8; PMID:9771862
-
(1998)
Am J Clin Nutr
, vol.68
, pp. 854-858
-
-
Trang, H.M.1
Cole, D.E.2
Rubin, L.A.3
Pierratos, A.4
Siu, S.5
Vieth, R.6
-
53
-
-
79251474745
-
Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials
-
PMID:20876671
-
Kandula P, Dobre M, Schold JD, Schreiber MJ, Jr., Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011; 6:50-62; PMID:20876671; http://dx.doi.org/10.2215/ CJN.03940510
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 50-62
-
-
Kandula, P.1
Dobre, M.2
Schold, J.D.3
Schreiber Jr., M.J.4
Mehrotra, R.5
Navaneethan, S.D.6
-
54
-
-
34948856442
-
Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol
-
PMID: 17667981
-
Repo JM, Rantala IS, Honkanen TT, Mustonen JT, Kööbi P, Tahvanainen AM, et al. Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol. Kidney Int 2007; 72:977-84; PMID: 17667981; http://dx.doi.org/10.1038/sj.ki.5002458
-
(2007)
Kidney Int
, vol.72
, pp. 977-984
-
-
Repo, J.M.1
Rantala, I.S.2
Honkanen, T.T.3
Mustonen, J.T.4
Kööbi, P.5
Tahvanainen, A.M.6
-
55
-
-
33747075392
-
25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells
-
PMID:16807549
-
Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 2006; 70:654-9; PMID:16807549; http://dx.doi.org/10.1038/sj.ki.5000394
-
(2006)
Kidney Int
, vol.70
, pp. 654-659
-
-
Ritter, C.S.1
Armbrecht, H.J.2
Slatopolsky, E.3
Brown, A.J.4
-
56
-
-
79957827666
-
Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
-
PMID: 21289598
-
Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et al. Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79:1331-40; PMID: 21289598; http://dx.doi.org/10.1038/ki.2010.550
-
(2011)
Kidney Int
, vol.79
, pp. 1331-1340
-
-
Astor, B.C.1
Matsushita, K.2
Gansevoort, R.T.3
Van Der Velde, M.4
Woodward, M.5
Levey, A.S.6
-
57
-
-
26944473274
-
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease
-
PMID:16014054
-
Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005; 68:766-72; PMID:16014054
-
(2005)
Kidney Int
, vol.68
, pp. 766-772
-
-
Menon, V.1
Greene, T.2
Wang, X.3
Pereira, A.A.4
Marcovina, S.M.5
Beck, G.J.6
-
58
-
-
34250762524
-
25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)
-
PMID:17591526
-
de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2007; 50:69-77; PMID:17591526; http://dx.doi.org/10.1053/j.ajkd.2007.04.015
-
(2007)
Am J Kidney Dis
, vol.50
, pp. 69-77
-
-
De Boer, I.H.1
Ioannou, G.N.2
Kestenbaum, B.3
Brunzell, J.D.4
Weiss, N.S.5
-
59
-
-
79959230591
-
Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: Complex interactions
-
PMID: 20817560
-
Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr 2011; 21:295-302; PMID: 20817560; http://dx.doi.org/10.1053/j.jrn.2010.07.002
-
(2011)
J Ren Nutr
, vol.21
, pp. 295-302
-
-
Isakova, T.1
Gutiérrez, O.M.2
Patel, N.M.3
Andress, D.L.4
Wolf, M.5
Levin, A.6
-
60
-
-
83055169698
-
Vitamin D: Roles in renal and cardiovascular protection
-
PMID:22143249
-
Li YC. Vitamin D: roles in renal and cardiovascular protection. Curr Opin Nephrol Hypertens 2012; 21:72-9; PMID:22143249; http://dx.doi.org/10.1097/MNH. 0b013e32834de4ee
-
(2012)
Curr Opin Nephrol Hypertens
, vol.21
, pp. 72-79
-
-
Li, Y.C.1
-
61
-
-
77954759029
-
Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality
-
PMID: 20359533
-
Dusso A, Arcidiacono MV, Yang J, Tokumoto M. Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality. J Steroid Biochem Mol Biol 2010; 121:193-8; PMID: 20359533; http://dx.doi.org/10.1016/j. jsbmb.2010.03.064
-
(2010)
J Steroid Biochem Mol Biol
, vol.121
, pp. 193-198
-
-
Dusso, A.1
Arcidiacono, M.V.2
Yang, J.3
Tokumoto, M.4
-
62
-
-
69449086668
-
ADAM17 upregulation in human renal disease: A role in modulating TGF-alpha availability?
-
PMID:19535569
-
Melenhorst WB, Visser L, Timmer A, van den Heuvel MC, Stegeman CA, van Goor H. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? Am J Physiol Renal Physiol 2009; 297:F781-90; PMID:19535569; http://dx.doi.org/10.1152/ajprenal.90610.2008
-
(2009)
Am J Physiol Renal Physiol
, vol.297
-
-
Melenhorst, W.B.1
Visser, L.2
Timmer, A.3
Van Den Heuvel, M.C.4
Stegeman, C.A.5
Van Goor, H.6
-
63
-
-
80052758537
-
Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression
-
PMID:21803771
-
Deb DK, Wang Y, Zhang Z, Nie H, Huang X, Yuan Z, et al. Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression. J Biol Chem 2011; 286:32011-7; PMID:21803771; http://dx.doi.org/10. 1074/jbc.M111.269118
-
(2011)
J Biol Chem
, vol.286
, pp. 32011-32017
-
-
Deb, D.K.1
Wang, Y.2
Zhang, Z.3
Nie, H.4
Huang, X.5
Yuan, Z.6
-
64
-
-
0031951097
-
Regulation of gp330/megalin expression by vitamins A and D
-
PMID:9541123
-
Liu W, Yu WR, Carling T, Juhlin C, Rastad J, Ridefelt P, et al. Regulation of gp330/megalin expression by vitamins A and D. Eur J Clin Invest 1998; 28:100-7; PMID:9541123; http://dx.doi.org/10.1046/j.1365-2362.1998.00253.x
-
(1998)
Eur J Clin Invest
, vol.28
, pp. 100-107
-
-
Liu, W.1
Yu, W.R.2
Carling, T.3
Juhlin, C.4
Rastad, J.5
Ridefelt, P.6
-
65
-
-
32844466369
-
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
-
PMID:16316359
-
Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 2005; 68:2823-8; PMID:16316359; http://dx.doi.org/10.1111/j.1523-1755.2005. 00755.x
-
(2005)
Kidney Int
, vol.68
, pp. 2823-2828
-
-
Agarwal, R.1
Acharya, M.2
Tian, J.3
Hippensteel, R.L.4
Melnick, J.Z.5
Qiu, P.6
-
66
-
-
49849104171
-
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: A randomized double-blind pilot trial
-
PMID:18606901
-
Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z, et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 2008; 52:249-55; PMID:18606901; http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.113159
-
(2008)
Hypertension
, vol.52
, pp. 249-255
-
-
Alborzi, P.1
Patel, N.A.2
Peterson, C.3
Bills, J.E.4
Bekele, D.M.5
Bunaye, Z.6
-
67
-
-
78149359262
-
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial
-
PMID:21055801
-
de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010; 376:1543-51; PMID:21055801; http://dx.doi.org/10. 1016/S0140-6736(10)61032-X
-
(2010)
Lancet
, vol.376
, pp. 1543-1551
-
-
De Zeeuw, D.1
Agarwal, R.2
Amdahl, M.3
Audhya, P.4
Coyne, D.5
Garimella, T.6
-
68
-
-
70349251198
-
Oral paricalcitol in the treatment of patients with CKD and proteinuria: A randomized trial
-
PMID:19596163
-
Fishbane S, Chittineni H, Packman M, Dutka P, Ali N, Durie N. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. Am J Kidney Dis 2009; 54:647-52; PMID:19596163; http://dx.doi.org/10. 1053/j.ajkd.2009.04.036
-
(2009)
Am J Kidney Dis
, vol.54
, pp. 647-652
-
-
Fishbane, S.1
Chittineni, H.2
Packman, M.3
Dutka, P.4
Ali, N.5
Durie, N.6
-
69
-
-
80155151894
-
Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration
-
PMID:22042029
-
Weir MR. Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration. Kidney Int 2011; 80:1016-7; PMID:22042029; http://dx.doi.org/10.1038/ki.2011.265
-
(2011)
Kidney Int
, vol.80
, pp. 1016-1017
-
-
Weir, M.R.1
-
70
-
-
79959732598
-
Diets and enteral supplements for improving outcomes in chronic kidney disease
-
PMID: 21629229
-
Kalantar-Zadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, Mak RH, et al. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol 2011; 7:369-84; PMID: 21629229; http://dx.doi.org/10.1038/ nrneph.2011.60
-
(2011)
Nat Rev Nephrol
, vol.7
, pp. 369-384
-
-
Kalantar-Zadeh, K.1
Cano, N.J.2
Budde, K.3
Chazot, C.4
Kovesdy, C.P.5
Mak, R.H.6
-
71
-
-
49649111989
-
Association of oral calcitriol with improved survival in nondialyzed CKD
-
PMID:18463168
-
Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B. Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 2008; 19:1613-9; PMID:18463168; http://dx.doi.org/10.1681/ASN.2007111164
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1613-1619
-
-
Shoben, A.B.1
Rudser, K.D.2
De Boer, I.H.3
Young, B.4
Kestenbaum, B.5
-
72
-
-
80051788638
-
Chronic kidney disease and risk of death from infection
-
PMID:21860228
-
Wang HE, Gamboa C, Warnock DG, Muntner P. Chronic kidney disease and risk of death from infection. Am J Nephrol 2011; 34:330-6; PMID:21860228; http://dx.doi.org/10.1159/000330673
-
(2011)
Am J Nephrol
, vol.34
, pp. 330-336
-
-
Wang, H.E.1
Gamboa, C.2
Warnock, D.G.3
Muntner, P.4
-
73
-
-
80054046948
-
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages
-
PMID: 21998409
-
Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, et al. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011; 3:ra102; PMID: 21998409; http://dx.doi.org/10. 1126/scitranslmed.3003045
-
(2011)
Sci Transl Med
, vol.3
-
-
Fabri, M.1
Stenger, S.2
Shin, D.M.3
Yuk, J.M.4
Liu, P.T.5
Realegeno, S.6
-
74
-
-
0025935017
-
In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients
-
PMID:1662316
-
Hübel E, Kiefer T, Weber J, Mettang T, Kuhlmann U. In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients. Kidney Int 1991; 40:927-33; PMID:1662316; http://dx.doi.org/10.1038/ki.1991.296
-
(1991)
Kidney Int
, vol.40
, pp. 927-933
-
-
Hübel, E.1
Kiefer, T.2
Weber, J.3
Mettang, T.4
Kuhlmann, U.5
-
75
-
-
33645224419
-
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
-
PMID:16497887
-
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3; PMID:16497887; http://dx.doi.org/10.1126/science. 1123933
-
(2006)
Science
, vol.311
, pp. 1770-1773
-
-
Liu, P.T.1
Stenger, S.2
Li, H.3
Wenzel, L.4
Tan, B.H.5
Krutzik, S.R.6
-
76
-
-
77956934530
-
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients
-
PMID:20688781
-
Drechsler C, Pilz S, Obermayer-Pietsch B, Verduijn M, Tomaschitz A, Krane V, et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010; 31:2253-61; PMID:20688781; http://dx.doi.org/10.1093/eurheartj/ ehq246
-
(2010)
Eur Heart J
, vol.31
, pp. 2253-2261
-
-
Drechsler, C.1
Pilz, S.2
Obermayer-Pietsch, B.3
Verduijn, M.4
Tomaschitz, A.5
Krane, V.6
-
77
-
-
45749148626
-
Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: A 3-y prospective cohort study
-
PMID:18541550
-
Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008; 87:1631-8; PMID:18541550
-
(2008)
Am J Clin Nutr
, vol.87
, pp. 1631-1638
-
-
Wang, A.Y.1
Lam, C.W.2
Sanderson, J.E.3
Wang, M.4
Chan, I.H.5
Lui, S.F.6
-
78
-
-
38449117963
-
Meta-analysis: Vitamin D compounds in chronic kidney disease
-
PMID:18087055
-
Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007; 147:840-53; PMID:18087055
-
(2007)
Ann Intern Med
, vol.147
, pp. 840-853
-
-
Palmer, S.C.1
McGregor, D.O.2
Macaskill, P.3
Craig, J.C.4
Elder, G.J.5
Strippoli, G.F.6
-
79
-
-
32844463195
-
Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis
-
PMID:16166802
-
Kim HW, Park CW, Shin YS, Kim YS, Shin SJ, Kim YS, et al. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin Pract 2006; 102:c21-9; PMID:16166802; http://dx.doi.org/10.1159/000088295
-
(2006)
Nephron Clin Pract
, vol.102
-
-
Kim, H.W.1
Park, C.W.2
Shin, Y.S.3
Kim, Y.S.4
Shin, S.J.5
Kim, Y.S.6
-
80
-
-
0036073755
-
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system
-
PMID:12122115
-
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:229-38; PMID:12122115
-
(2002)
J Clin Invest
, vol.110
, pp. 229-238
-
-
Li, Y.C.1
Kong, J.2
Wei, M.3
Chen, Z.F.4
Liu, S.Q.5
Cao, L.P.6
-
81
-
-
79955445900
-
Shining D'light on chronic kidney disease: Mechanisms that may underpin the cardiovascular benefit of vitamin D
-
Carlton PMID: 21323790
-
Petchey WG, Johnson DW, Isbel NM. Shining D'light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D. Nephrology (Carlton) 2011; 16:351-67; PMID: 21323790; http://dx.doi.org/10.1111/ j.1440-1797.2011.01450.x
-
(2011)
Nephrology
, vol.16
, pp. 351-367
-
-
Petchey, W.G.1
Johnson, D.W.2
Isbel, N.M.3
-
82
-
-
77950447766
-
Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis
-
PMID: 20011094
-
Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010:351385; PMID: 20011094; http://dx.doi.org/10.1155/2010/351385
-
(2010)
Int J Endocrinol
, vol.2010
, pp. 351385
-
-
Alvarez, J.A.1
Ashraf, A.2
-
83
-
-
33645283341
-
Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels
-
PMID:16455676
-
Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant 2006; 21:889-97; PMID:16455676; http://dx.doi.org/10.1093/ndt/gfi254
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 889-897
-
-
Cohen-Lahav, M.1
Shany, S.2
Tobvin, D.3
Chaimovitz, C.4
Douvdevani, A.5
-
84
-
-
79952040900
-
Calcitriol counteracts endothelial cell proinflammatory processes in a chronic kidney disease-like environment
-
PMID:21236342
-
Talmor-Barkan Y, Bernheim J, Green J, Benchetrit S, Rashid G. Calcitriol counteracts endothelial cell proinflammatory processes in a chronic kidney disease-like environment. J Steroid Biochem Mol Biol 2011; 124:19-24; PMID:21236342; http://dx.doi.org/10.1016/j.jsbmb.2011.01.001
-
(2011)
J Steroid Biochem Mol Biol
, vol.124
, pp. 19-24
-
-
Talmor-Barkan, Y.1
Bernheim, J.2
Green, J.3
Benchetrit, S.4
Rashid, G.5
-
85
-
-
79953035853
-
Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism
-
PMID:21426509
-
Tanaka M, Tokunaga K, Komaba H, Itoh K, Matsushita K, Watanabe H, et al. Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial 2011; 15:161-8; PMID:21426509; http://dx.doi.org/10.1111/j.1744-9987.2010.00890.x
-
(2011)
Ther Apher Dial
, vol.15
, pp. 161-168
-
-
Tanaka, M.1
Tokunaga, K.2
Komaba, H.3
Itoh, K.4
Matsushita, K.5
Watanabe, H.6
-
86
-
-
1842373332
-
Intravenous alfacalcidol improves insulin resistance in hemodialysis patients
-
PMID:9285148
-
Günal AI, Celiker H, Celebi H, Ustündaǧ B, Günal SY. Intravenous alfacalcidol improves insulin resistance in hemodialysis patients. Clin Nephrol 1997; 48:109-13; PMID:9285148
-
(1997)
Clin Nephrol
, vol.48
, pp. 109-113
-
-
Günal, A.I.1
Celiker, H.2
Celebi, H.3
Ustündaǧ, B.4
Günal, S.Y.5
-
87
-
-
0028910725
-
Intravenous calcitriol normalizes insulin sensitivity in uremic patients
-
PMID:7731147
-
Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995; 47:200-6; PMID:7731147; http://dx.doi.org/10.1038/ki.1995.24
-
(1995)
Kidney Int
, vol.47
, pp. 200-206
-
-
Kautzky-Willer, A.1
Pacini, G.2
Barnas, U.3
Ludvik, B.4
Streli, C.5
Graf, H.6
-
88
-
-
0026632581
-
Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients
-
PMID: 1498003
-
Mak RH. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 1992; 6:345-8; PMID: 1498003; http://dx.doi.org/10.1007/BF00869730
-
(1992)
Pediatr Nephrol
, vol.6
, pp. 345-348
-
-
Mak, R.H.1
-
89
-
-
0026523822
-
Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients
-
PMID:1513086
-
Mak RH. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992; 41:1049-54; PMID:1513086; http://dx.doi.org/10.1038/ki.1992.159
-
(1992)
Kidney Int
, vol.41
, pp. 1049-1054
-
-
Mak, R.H.1
-
90
-
-
0031816036
-
1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia
-
PMID:9573552
-
Mak RH. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 1998; 53:1353-7; PMID:9573552; http://dx.doi.org/10.1046/ j.1523-1755.1998.00865.x
-
(1998)
Kidney Int
, vol.53
, pp. 1353-1357
-
-
Mak, R.H.1
-
91
-
-
77952316154
-
Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters
-
PMID:20203163
-
Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010; 5:905-11; PMID:20203163; http://dx.doi.org/10.2215/CJN.06510909
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 905-911
-
-
Matias, P.J.1
Jorge, C.2
Ferreira, C.3
Borges, M.4
Aires, I.5
Amaral, T.6
-
92
-
-
0032893965
-
Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism
-
PMID:9915270
-
Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33:73-81; PMID:9915270; http://dx.doi.org/10.1016/S0272-6386(99)70260-X
-
(1999)
Am J Kidney Dis
, vol.33
, pp. 73-81
-
-
Park, C.W.1
Oh, Y.S.2
Shin, Y.S.3
Kim, C.M.4
Kim, Y.S.5
Kim, S.Y.6
-
93
-
-
77949378067
-
Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD
-
PMID:20007751
-
Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 2010; 21:353-61; PMID:20007751; http://dx.doi.org/10.1681/ASN.2009040451
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 353-361
-
-
Stubbs, J.R.1
Idiculla, A.2
Slusser, J.3
Menard, R.4
Quarles, L.D.5
|